The U.S. Sexually Transmitted Infections (STI) National Strategic Plan includes, but is not limited to, vaccine and treatment research focused on chlamydia, gonorrhea, and Mpox.
According to recent STI reports, additional clinical evaluations and research are needed for these diseases.
Sexually Transmitted Disease Treatment and Vaccines Remain Underwhelming
Sexually Transmitted Disease Vaccine Development Remain Underwhelming
The U.S. Sexually Transmitted Infections (STI) National Strategic Plan includes, but is not limited to, vaccine and treatment research focused on chlamydia, gonorrhea, and Mpox.
According to recent STI reports, additional clinical evaluations and research are needed for these diseases.
Broadly Neutralizing Antibody Could Lead to Zika Vaccines
Researchers at Seattle’s Fred Hutchinson Cancer Center recently discovered a potent antibody that appears to block mosquito-borne viruses.
The newly found antibody can block the Zika virus, as well.
Fred Hutch researcher Leslie Goo, Ph.D., MPH, is an expert in flaviviruses, a family of pathogens that include Zika, dengue, West Nile, yellow fever, and Japanese encephalitis viruses.
Protein-based COVID-19 Vaccine Over 79% Effective
The JAMA Network today published the results from an Original Investigation on the Novavax COVID-19 vaccine.
In collaboration with the Department of Health and Human Services, Novavax researchers assessed the neutralizing antibody response to its COVID-19 vaccine (NVX-CoV2373) in a phase 3 clinical trial among adolescents from April 26 to June 5, 2021.
HIV Vaccine Research Accelerates with Government Funding
While millions of people worldwide await the launch of an HIV vaccine, the U.S. government recently took action by committing to fund early-stage vaccine candidates.
On April 26, 2023, Uvax Bio, LLC announced that its HIV vaccine candidates had shown significantly improved immune response compared with current vaccine strategies.
Rift River Fever Vaccine Candidate Competes Phase 1 Study
In this issue of The Lancet Infectious Diseases, Daniel Jenkin and colleagues reported the results of a phase 1 study of a new ChAdOx1 vector vaccine against Rift Valley fever (RVF).
RVF is a viral zoonosis that primarily affects animals but can infect humans.
The development of an effective human vaccine against RVF that elicits a long-term immune response is of enormous clinical importance, wrote these researchers on April 12, 2023.
New Malaria Vaccine Takes Orders
Two African nations became the first countries to approve the new R21/Matrix-M™ malaria vaccine, developed at Oxford University, includes Novavax's world-class adjuvant, and is manufactured by the Serum Institute of India (SII), Pvt. Ltd.
This year, Ghana and Nigeria preempted the World Health Organization (WHO) process and issued their approvals. And about ten other African countries may issue their approvals soon.
U.S. NIH Herpes Strategic Plan Seeks Proposals
Over the past decade, the United States has witnessed alarming increases in rates of sexually transmitted infections (STIs), amounting to a public health crisis.
The consequences of the STI epidemic are enormous, wrote the U.S. HHS.
When left untreated, STIs can lead to long-term, irreversible health outcomes such as chronic pelvic pain, infertility, adverse pregnancy outcomes, neonatal death, and congenital abnormalities.
Where Did This Bird Flu Outbreak Originate
A team of researchers has tracked the arrival and progression of H5N1 bird flu (Avian influenza) outbreaks in Canada, Mexico, and the United States.
Led by the University of Maryland (UMD) researchers, this team found an unusual change from seasonal highly pathogenic avian influenza (HAPI) to year-round infections and a far more significant impact on birds, mammals, and people.
Which Sexually Transmitted Disease is Vaccine-Preventable
While several sexually transmitted diseases (STDs) lack preventive vaccines, such as herpes, HIV, and chlamydia, cervical cancer is a disease that can be prevented with an effective vaccine.
Furthermore, real-world data indicates only one dose is needed to protect certain women from this cancer.